#16137-2 – Men and Women with Liver Disease

Location: Denver

Stay: 8 nights/9 days

Gender: Male/Female

Ages: 18-75

Compensation: $2550

Smokers Allowed: Yes

Study Overview:

This study is being done to compare how relugolix is broken down by the body in people with varying degrees of liver disease compared to healthy volunteers who are similar in gender, age and weight. It is also being done to determine the safety and tolerability of a single dose of relugolix in people with liver disease.

Enroll In This Study